SELLAS Life Sciences Group, Inc.
SLS
SLS
Nasdaq
Health Technology
Pharmaceuticals: Major
9.98
USD-1.36
-11.99%
Closed: 10-16 20:00 (UTC+0)
10.08
USD+0.0991
+0.99%
After Hours: 10-16 23:08 (UTC+0)
SLS Key Statistics
High
11.24
Open
11.17
Volume
15.28M
Low
9.75
Prev. Close
11.34
Trading Value
153.27M
52-Week High
15.88
Relative Volume
3.565
Amplitude (%)
13.14%
52-Week Low
1.39
Turnover Rate
7.57%
Market Cap
2.01B
P/E Ratio (TTM)
--
P/E Ratio (Annual)
--
P/B Ratio
16.64
P/S Ratio
--
Earnings Per Share (EPS)
-0.212
Dividend (TTM)
0
Dividend Yield
0.00%
Shares Outstanding
201.94M
Currency Unit
USD
SLS Price Performance
7 day
30 day
90 day
180 day
Year to date
1 Year
SLS Money Flow Distribution
SLS Daily Short Sale Volume
SLS Short Interest History
SLS Stock Snapshot
As of 2026-10-16, the SELLAS Life Sciences Group, Inc. (SLS) stock price today is 9.98. Based on this price, the company has a market capitalization of $2.01B, with a P/E ratio of --.
On 2026-10-16, SLS traded between 9.75 and 11.24. Today’s stock price is 2.36% above the daily low and 11.21% below the daily high, placing SLS near the lower end of its most recent trading range.
Trading volume currently stands at 15.28M, compared with an average daily volume of 4.28M. This suggests that trading activity is significantly above its usual level than usual.
Over the past year, SELLAS Life Sciences Group, Inc. shares have traded between 1.39 and 15.88. At today’s price, SLS is 617.99% above its 52-week low and 37.15% below its 52-week high.
SLS Related News
About SLS
Company Name
SELLAS Life Sciences Group, Inc.
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchanges
Nasdaq
Number of Employees
13
Lot Size
100
Official Website
Currency Unit
USD
SELLAS Life Sciences Group, Inc. (SLS) is a late-stage biopharmaceutical company developing cancer immunotherapies. Its programs include galinpepimut-S, a WT1-targeted vaccine, and SLS009, a selective CDK9 inhibitor.
Related Stocks
SLS FAQ
1.What is the live stock price of SELLAS Life Sciences Group, Inc. (SLS) today?
As of 2026-10-16 20:00 (UTC+0), SELLAS Life Sciences Group, Inc. (SLS) is trading at $9.98, down $1.36 (-11.99%) from the previous trading day’s closing price of $11.34.
3. What were SLS’s trading range and trading volume on the most recent trading day?
On the most recent trading day (2026-10-16 20:00 (UTC+0)), SLS opened at $11.17, reached a high of $11.24, and recorded a low of $9.75. Trading volume for the day was 15.29M, with a total trading value of $153.27M.
The trading volume on that day was 3.56x the average daily volume.
What is the latest after-hours price of SLS?
As of 2026-10-16 23:07 (UTC+0), SLS’s latest after-hours price was $10.08, up $0.10 (+0.99%) from the previous trading day’s close.
7. What are SLS’s 52-week high and 52-week low?
Over the past 52 weeks, SLS has traded between $1.39 and $15.88. Based on the current price, SLS is 625.12% above its 52-week low and 36.52% below its 52-week high.
9. What are SLS’s short sale volume and short interest?
On undefined, SLS had a short sale volume of -- shares, with a short sale ratio of -- and a Nasdaq short sale ratio of --.
As of --, SLS had short interest of -- shares, an average daily trading volume of -- shares, and days to cover.
Short sale volume reflects short-sale transactions on a given day, while short interest reflects short positions that remain open.
11. What are SELLAS Life Sciences Group, Inc.’s P/E ratio and valuation metrics?
As of 2026-10-16 23:18 (UTC+0), SELLAS Life Sciences Group, Inc. has a trailing price-to-earnings ratio, or P/E (TTM), of --, an annual P/E ratio of --, a price-to-book ratio of 16.64, and a price-to-sales ratio of --.
These valuation metrics reflect the relationship between a company’s market price and its earnings, net assets, and revenue. Reasonable valuation levels can vary significantly across companies and industries.
13. What were SELLAS Life Sciences Group, Inc.’s revenue and net income in the most recent quarter?
For the most recent quarter, SELLAS Life Sciences Group, Inc. reported revenue of -- and net income of --. Revenue was -- -- year over year, while net income was -- -- year over year.
15.What is SELLAS Life Sciences Group, Inc.’s total number of shares outstanding?
SELLAS Life Sciences Group, Inc. has 201.95M shares outstanding. Total shares outstanding refers to the total number of shares issued by the company and held by investors.
17. Which exchange is SELLAS Life Sciences Group, Inc. listed on, and what sector and industry does it belong to?
SELLAS Life Sciences Group, Inc. (SLS) is listed on Nasdaq. It belongs to the Health Technology sector and the Pharmaceuticals: Major industry.
Sector and industry classifications can help investors understand the company’s primary business area and compare it with other publicly traded companies in the same industry.
19. What risks should investors consider before investing in SLS?
Before investing in SLS, investors should consider changes in SELLAS Life Sciences Group, Inc.’s revenue and profitability, valuation levels, industry competition, operational risks, the macroeconomic environment, and stock price volatility. Analyst forecasts and technical indicators may change and should not be used as the sole basis for investment decisions.
2.What is the ticker symbol for SELLAS Life Sciences Group, Inc.?
The ticker symbol for SELLAS Life Sciences Group, Inc. is SLS.
4. What is the latest pre-market price of SLS?
As of 2026-10-16 13:29 (UTC+0), SLS’s latest pre-market price was $11.17, down $0.17 (-1.50%) from the previous trading day’s close.
6.How has SLS’s stock price performed recently?
As of 2026-10-16 23:18 (UTC+0), SLS is down NaN% over the past 7 days, down NaN% over the past 30 days, down NaN% year to date, and down NaN% over the past year.
Past price performance reflects historical gains and losses only and is not indicative of future performance.
8. What is the current capital flow for SLS?
As of 2026-10-16 23:18 (UTC+0), SLS recorded a net capital outflow of $NaN. Of this, net large-order inflow was $0, net medium-order inflow was $0, and net small-order outflow was $0.
A positive net capital inflow generally indicates that buying activity exceeded selling activity, while a negative value indicates relatively greater selling activity. Capital flows may continue to change as market trading progresses.
10. What is the current price of NVDA stock perps?
As of 2026-10-16 23:18 (UTC+0), the live price of SLS stock perps is --, with a 24-hour change of --.
Total open interest in SLS stock perps is currently --, with a 24-hour trading volume of -- and an open-interest-weighted funding rate of --.
Stock perps are offered by cryptocurrency trading platforms and are different trading products from shares listed on securities exchanges. Their prices, liquidity and trading hours may differ.
CoinGlass currently provides live prices, funding rates, open interest, trading volume, liquidations, long/short ratios and market data across exchanges for stock perps.
12. What is the market capitalization of SELLAS Life Sciences Group, Inc.?
As of 2026-10-16 23:18 (UTC+0), SELLAS Life Sciences Group, Inc. has a market capitalization of approximately $2.02B. Market capitalization is calculated based on the current stock price and the company’s total shares outstanding and may fluctuate as the stock price changes.
14. What is SELLAS Life Sciences Group, Inc.’s earnings per share (EPS)?
Based on trailing twelve-month data, SELLAS Life Sciences Group, Inc.’s earnings per share, or EPS (TTM), is -$0.21. EPS measures the amount of a company’s earnings attributable to each outstanding share of common stock.
16. Does SELLAS Life Sciences Group, Inc. pay dividends?
SELLAS Life Sciences Group, Inc. paid dividends of 0.000 per share over the trailing twelve months. Based on the current stock price, its dividend yield is approximately 0.00%. Future dividend amounts and payment dates may change.
18. How many employees does SELLAS Life Sciences Group, Inc. have?
Based on the latest available company data, SELLAS Life Sciences Group, Inc. had approximately 13 employees as of 2026-10-16. The number of employees may vary due to workforce changes, the reporting date, and differences in disclosure methodology.
1.What is the live stock price of SELLAS Life Sciences Group, Inc. (SLS) today?
As of 2026-10-16 20:00 (UTC+0), SELLAS Life Sciences Group, Inc. (SLS) is trading at $9.98, down $1.36 (-11.99%) from the previous trading day’s closing price of $11.34.
2.What is the ticker symbol for SELLAS Life Sciences Group, Inc.?
The ticker symbol for SELLAS Life Sciences Group, Inc. is SLS.
3. What were SLS’s trading range and trading volume on the most recent trading day?
On the most recent trading day (2026-10-16 20:00 (UTC+0)), SLS opened at $11.17, reached a high of $11.24, and recorded a low of $9.75. Trading volume for the day was 15.29M, with a total trading value of $153.27M.
The trading volume on that day was 3.56x the average daily volume.
4. What is the latest pre-market price of SLS?
As of 2026-10-16 13:29 (UTC+0), SLS’s latest pre-market price was $11.17, down $0.17 (-1.50%) from the previous trading day’s close.
What is the latest after-hours price of SLS?
As of 2026-10-16 23:07 (UTC+0), SLS’s latest after-hours price was $10.08, up $0.10 (+0.99%) from the previous trading day’s close.
6.How has SLS’s stock price performed recently?
As of 2026-10-16 23:18 (UTC+0), SLS is down NaN% over the past 7 days, down NaN% over the past 30 days, down NaN% year to date, and down NaN% over the past year.
Past price performance reflects historical gains and losses only and is not indicative of future performance.
7. What are SLS’s 52-week high and 52-week low?
Over the past 52 weeks, SLS has traded between $1.39 and $15.88. Based on the current price, SLS is 625.12% above its 52-week low and 36.52% below its 52-week high.
8. What is the current capital flow for SLS?
As of 2026-10-16 23:18 (UTC+0), SLS recorded a net capital outflow of $NaN. Of this, net large-order inflow was $0, net medium-order inflow was $0, and net small-order outflow was $0.
A positive net capital inflow generally indicates that buying activity exceeded selling activity, while a negative value indicates relatively greater selling activity. Capital flows may continue to change as market trading progresses.
9. What are SLS’s short sale volume and short interest?
On undefined, SLS had a short sale volume of -- shares, with a short sale ratio of -- and a Nasdaq short sale ratio of --.
As of --, SLS had short interest of -- shares, an average daily trading volume of -- shares, and days to cover.
Short sale volume reflects short-sale transactions on a given day, while short interest reflects short positions that remain open.
10. What is the current price of NVDA stock perps?
As of 2026-10-16 23:18 (UTC+0), the live price of SLS stock perps is --, with a 24-hour change of --.
Total open interest in SLS stock perps is currently --, with a 24-hour trading volume of -- and an open-interest-weighted funding rate of --.
Stock perps are offered by cryptocurrency trading platforms and are different trading products from shares listed on securities exchanges. Their prices, liquidity and trading hours may differ.
CoinGlass currently provides live prices, funding rates, open interest, trading volume, liquidations, long/short ratios and market data across exchanges for stock perps.
11. What are SELLAS Life Sciences Group, Inc.’s P/E ratio and valuation metrics?
As of 2026-10-16 23:18 (UTC+0), SELLAS Life Sciences Group, Inc. has a trailing price-to-earnings ratio, or P/E (TTM), of --, an annual P/E ratio of --, a price-to-book ratio of 16.64, and a price-to-sales ratio of --.
These valuation metrics reflect the relationship between a company’s market price and its earnings, net assets, and revenue. Reasonable valuation levels can vary significantly across companies and industries.
12. What is the market capitalization of SELLAS Life Sciences Group, Inc.?
As of 2026-10-16 23:18 (UTC+0), SELLAS Life Sciences Group, Inc. has a market capitalization of approximately $2.02B. Market capitalization is calculated based on the current stock price and the company’s total shares outstanding and may fluctuate as the stock price changes.
13. What were SELLAS Life Sciences Group, Inc.’s revenue and net income in the most recent quarter?
For the most recent quarter, SELLAS Life Sciences Group, Inc. reported revenue of -- and net income of --. Revenue was -- -- year over year, while net income was -- -- year over year.
14. What is SELLAS Life Sciences Group, Inc.’s earnings per share (EPS)?
Based on trailing twelve-month data, SELLAS Life Sciences Group, Inc.’s earnings per share, or EPS (TTM), is -$0.21. EPS measures the amount of a company’s earnings attributable to each outstanding share of common stock.
15.What is SELLAS Life Sciences Group, Inc.’s total number of shares outstanding?
SELLAS Life Sciences Group, Inc. has 201.95M shares outstanding. Total shares outstanding refers to the total number of shares issued by the company and held by investors.
16. Does SELLAS Life Sciences Group, Inc. pay dividends?
SELLAS Life Sciences Group, Inc. paid dividends of 0.000 per share over the trailing twelve months. Based on the current stock price, its dividend yield is approximately 0.00%. Future dividend amounts and payment dates may change.
17. Which exchange is SELLAS Life Sciences Group, Inc. listed on, and what sector and industry does it belong to?
SELLAS Life Sciences Group, Inc. (SLS) is listed on Nasdaq. It belongs to the Health Technology sector and the Pharmaceuticals: Major industry.
Sector and industry classifications can help investors understand the company’s primary business area and compare it with other publicly traded companies in the same industry.
18. How many employees does SELLAS Life Sciences Group, Inc. have?
Based on the latest available company data, SELLAS Life Sciences Group, Inc. had approximately 13 employees as of 2026-10-16. The number of employees may vary due to workforce changes, the reporting date, and differences in disclosure methodology.
19. What risks should investors consider before investing in SLS?
Before investing in SLS, investors should consider changes in SELLAS Life Sciences Group, Inc.’s revenue and profitability, valuation levels, industry competition, operational risks, the macroeconomic environment, and stock price volatility. Analyst forecasts and technical indicators may change and should not be used as the sole basis for investment decisions.
© 2026 CoinGlass, all rights reserved
